|
|
Volumn 150, Issue 3, 2000, Pages 349-350
|
|
Massive serum creatine kinase increases with atypical antipsychotic drugs: What is the mechanism and the message?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 IODO 2,5 DIMETHOXYAMPHETAMINE;
CLOZAPINE;
CREATINE KINASE MM;
DOPAMINE 2 RECEPTOR BLOCKING AGENT;
INSULIN;
KETANSERIN;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
RITANSERIN;
SEROTONIN;
SEROTONIN 2A AGONIST;
SEROTONIN 2A ANTAGONIST;
SEROTONIN 2A RECEPTOR;
SEROTONIN 2C AGONIST;
SEROTONIN 2C ANTAGONIST;
ANXIETY NEUROSIS;
CREATINE KINASE BLOOD LEVEL;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
ENZYME ACTIVITY;
GLUCOSE TRANSPORT;
HUMAN;
INSULIN RESISTANCE;
MALIGNANT HYPERTHERMIA;
MANIC DEPRESSIVE PSYCHOSIS;
MOTOR NEURON DISEASE;
MUSCLE DISEASE;
NERVE CELL DIFFERENTIATION;
NERVE CELL PLASTICITY;
NERVE DEGENERATION;
NERVE SPROUTING;
NEUROLEPTIC MALIGNANT SYNDROME;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RECEPTOR UPREGULATION;
SCHIZOPHRENIA;
SKELETAL MUSCLE;
ANTIPSYCHOTIC AGENTS;
CREATINE KINASE;
HUMANS;
RECEPTOR, SEROTONIN, 5-HT2A;
RECEPTORS, SEROTONIN;
STIMULATION, CHEMICAL;
|
|
EID: 0033948240
PISSN: 00333158
EISSN: None
Source Type: Journal
DOI: 10.1007/s002130000465 Document Type: Note |
|
Times cited : (40)
|
|
References (18)
|
